Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
68.2M
-
Shares change
-
+550K
-
Total reported value, excl. options
-
$2.42B
-
Value change
-
+$8.75M
-
Put/Call ratio
-
0.64
-
Number of buys
-
82
-
Number of sells
-
-95
-
Price
-
$35.48
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2020
245 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2020.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.2M shares
.
Largest 10 shareholders include FMR LLC (9M shares), WELLINGTON MANAGEMENT GROUP LLP (7.88M shares), VANGUARD GROUP INC (5.69M shares), BlackRock Inc. (4.53M shares), Capital International Investors (3.99M shares), Bellevue Group AG (3.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.7M shares), GOLDMAN SACHS GROUP INC (2.12M shares), STATE STREET CORP (1.91M shares), and ORBIMED ADVISORS LLC (1.65M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.